EN
HI
Bacil Pharma Chart
Bacil Pharma Share Key Metrics
Volume
926.00
Market Cap
69.97 CR
LTQ@LTP
100@48.75
ATP
49.83
Var Margin
25 %
Circuit Range
47.81-52.83
Delivery %
98.28 %
Value
46142.58
ASM/GSM
No
Market Lot
1
Summary
Bacil Pharma share price is ₹48.75 as of 3 Jun, 2026. The stock Bacil Pharma intraday movement has stayed between ₹48.01 and ₹52.80, while on a 52-week basis,Bacil Pharma price 52 week high is ₹61.80 & its 52 week low is ₹26.69.
In terms of trading activity, Bacil Pharma has recorded a volume of 926 shares, The Bacil Pharma has a market cap of ₹14353000 CR. The stock’s Average Traded Price (ATP) stands at ₹49.83, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 100 @ ₹48.75.
Bacil Pharma operates within a circuit range of ₹47.81 – ₹52.83, with a Value of ₹46142.58. The Delivery Percentage for the day is 98.28%. Additionally, Bacil Pharma currently falls under the No framework, and trades with a market lot size of 1.
Bacil Pharma Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.94
Sector P/B
2.97
Sec. Div. Yield
0.55
Bacil Pharma Resistance and Support
Pivot 50.87
Resistance
First Resistance
51.97
Second Resistance
53.61
Third Resistance
54.71
Support
First Support
49.23
Second Support
48.13
Third Support
46.49
Bacil Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-22 | Audited Results |
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-09-05 | Others |
| 2025-08-25 | Others |
| 2025-08-12 | Quarterly Results |
| 2025-07-16 | Others |
| 2025-05-26 | Audited Results |
| 2025-01-21 | Quarterly Results |
Bacil Pharma News
Bacil Pharma Ltd - 524516 - Board Meeting Outcome for Outcome Of Board Meeting For Audited Results For 31St March, 2026
Bacil Pharma approved audited financial results for FY26. The company reported a net loss of ₹164.14 lakhs, a significant increase from the ₹6.17 lakhs net loss in FY25. Revenue for the year declined by 66.69% to ₹66.14 lakhs.
May 22 2026 20:44:28
Bacil Pharma Ltd - 524516 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 22Nd May 2026
Bacil Pharma's Board of Directors will convene on May 22, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. This meeting also includes discussions on other board business.
May 11 2026 17:19:42
Bacil Pharma Management
| Name | Position |
|---|---|
| Dinesh Chander Notiyal | Non Executive Independent Director |
| Avani Savjibhai Godhaniya | Non Executive Independent Director |
Bacil Pharma Similar Stocks
Chennai Meenakshi Multispeciality Hospital Ltd.
38.79
-0.51 (1.30%)
Gujarat Inject (Kerala) Ltd.
109.10
-0.90 (0.82%)
Gujarat Terce Laboratories Ltd.
34.69
-0.37 (1.06%)
Ishita Drugs & Industries Ltd.
81.50
6.60 (8.81%)
Emmessar Biotech & Nutrition Ltd.
25.84
-0.56 (2.12%)
Cian Healthcare Ltd.
8.26
0.00 (0.00%)
Beryl Drugs Ltd.
21.49
0.31 (1.46%)
Bacil Pharma FAQs
The Buying Price of Bacil Pharma share is 48.75 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bacil Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bacil Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bacil Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bacil Pharma shares is 0. Useful to assess the stock's value relative to its book value.
To assess Bacil Pharma’s valuation compare Sector P/E, P/B which are 69.94 & 2.97 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bacil Pharma is 69.97 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bacil Pharma share price is 61.80 & 26.69. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bacil Pharma belongs to the Healthcare sector.
